Proteome Sciences Share Discussion Threads

[james japp] 14/2/2024 08:23

goatherd,

You are Joe Biden and I claim my £5.

[peverill] 14/2/2024 08:19

Is the company aware of this scenario??.Personally think it may be a revelation to them and they have missed a trick here.!!!!

[monte1] 14/2/2024 07:15

There is desperation and there is desperation, but this is desperation supercharged, twin turbocharged, nitrous oxide boosted and pimped to the max.

No matter, good morning all.

[goatherd] 13/2/2024 23:28

There are specialist financiers who provide funds in that situation. Mr Bates used them when he took the Post Office on, and won. (It is all available on a streaming service - well worth watching IMHO.)

But, if a company knows there is a clear, genuine, case they are unlikely to want to take it to court; much cheaper to settle, and they may manage to negotiate lower patent %s than a court would award - and they would avoid having to pay both sides costs.

[jeffian] 13/2/2024 23:27

Or as Jim Royle would have put it -

"Gateway? My @rse"

[jeffian] 13/2/2024 23:25

Let's face it; they're all avoiding the Toll Road and carrying on up the M6.

[the bull] 13/2/2024 23:12

I haven't really been following PRM for some time, I thought they were making progress but now they are relying on the Great Gateway of patent infringement you. How will they afford to take anyone on in court.

[goatherd] 13/2/2024 22:19

No peverill, I think it was serious. And also true.

[goatherd] 13/2/2024 22:16

elpirata,

I do not understand that sentence. Could you translate, please

[peverill] 13/2/2024 20:29

Is it Rednose day over on the educated thread.Surely that exchange between Richard and pools was all in jest.????

[dominiccummings] 13/2/2024 20:06

I wouldn't want to be out of these over the weekend....


Oh, and the MMs want your shares.

[elpirata] 13/2/2024 19:57

and you are surely a parody account goatherd

[goatherd] 13/2/2024 19:35

You overate the accuracy of journalists.

[elpirata] 13/2/2024 18:36

well heres your starter

"labs in the UK" could be Proteome, could they not?

Since when has Frankfurt been annexed by the UK?

tia

[goatherd] 13/2/2024 17:08

elpirita,

"labs in the UK" could be Proteome, could they not?

We all need to remember that use in trials does not need the patent holders permission. But clinical use does.

And the patent holder may well not even know that trials are being conducted. And will probably not be told if the patented idea is being used in the clinic - they have to find out for themselves.

Actually I believe the trials people may not even know they are using a patented product, I think it can come as a nasty shock.

A nice shock for shareholder's though.

[pools2] 13/2/2024 16:37

Jeffian, they probably will find a buyer.


edit:

Ok, so I'm not quite sure why I'm bothering to respond to this but, for the less well informed, trolls and numpties on here: -

Firstly, being the first 'commercial' test for p-tau 217 means absolutely nothing.

Secondly, an accurate Alzheimer's disease diagnostic, prognostic, theranostic test will consist of many different biomarker measures.

Thirdly, the most valuable aspect of AD biomarker IP will be for the design of therapeutics, not the relatively simple measure of disease state.

Finally, I believe Proteome Sciences has significant valuable intellectual property which is currently in the process of being granted, so therefore has very long patent life to approximately late 2030's early 2040's.

[jeffian] 13/2/2024 16:31

#59638,
Aye, close up shop. If the IP has any value, they should find a buyer to take it.

[pools2] 13/2/2024 16:31

There are significant hurdles for best funded companies. They mostly have to wait for a "consensus view" before producing a test or assay.

[goatherd] 13/2/2024 16:29

No Jeffian, I agree.

But, can you think of a better strategy?

[james japp] 13/2/2024 16:04

What a 'plan'.

Mothball the business with zero forward strategy.

[pools2] 13/2/2024 16:01

goatherd,

Agreed. Proteome Sciences state this in their reports and more recently in their webinars. Institutions and companies are now discovering the same Alzheimer's disease biomarkers that PRM have already discovered and patented.

[jeffian] 13/2/2024 15:59

Not so far, it isn't.